Pilgrim’s Pride (PPC) Q3 operating profit falls 61% despite Just Bare sales growth as chicken prices weaken
Read More Pharma Industry News AstraZeneca and Daiichi Sankyo win FDA approval for Enhertu combo as new standard in HER2 mBC Enhertu plus pertuzumab gets FDA approval for first-line HER2-positive mBC, setting a new standard in metastatic breast cancer care. Read what changes now. bySrinathDecember 17, 2025